Cart
sales@molnova.com
Suberic acid
CAS No. 505-48-6
Suberic acid( Octanedioic acid | 18-Octanedioic acid )
Catalog No. M19610 CAS No. 505-48-6
Suberic acid is present in the urine of patients with fatty acid oxidation disorders. A metabolic breakdown product derived from oleic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 500MG | 84 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSuberic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionSuberic acid is present in the urine of patients with fatty acid oxidation disorders. A metabolic breakdown product derived from oleic acid.
-
DescriptionSuberic acid is present in the urine of patients with fatty acid oxidation disorders. A metabolic breakdown product derived from oleic acid. Elevated levels of this unstaruated dicarboxylic acid are found in individuals with medium-chain acyl-CoA dehydrogenase deficiency (MCAD). Suberic acid is also associated with carnitine-acylcarnitine translocase deficiency malonyl-Coa decarboxylase deficiency.
-
In Vitro——
-
In Vivo——
-
SynonymsOctanedioic acid | 18-Octanedioic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number505-48-6
-
Formula Weight174.19
-
Molecular FormulaC8H14O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM;Water: 1.6 mg/mL
-
SMILESOC(=O)CCCCCCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gregersen N et al. General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.
molnova catalog
related products
-
β-Nicotinamide monon...
Nicotinamide ribotide (NMN) is an important intermediate metabolite in the nicotinate and nicotinamide metabolism pathway.
-
BAW2881
BAW2881 is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
-
PACAP-Related Peptid...
PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies.
